Imetelstat Trials for MF moves forward as FDA removes hold

Geron Corp announced today that the partial clinical hold on clinical trials of imetelstat in myelofibrosis has been removed by the FDA. The hold for essential thrombocythemia and polycythemia vera remains.

Click here for the full story.